You can find the annual or quarterly income statement of Crescent Biopharma Ord Shs here for insights into the performance and operational efficiency of Crescent Biopharma Ord Shs.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

Operating expenses

--25.89M

R&D expenses

--20.35M

Depreciation, depletion, and amortization

--28.00K

Operating profit

---25.89M

Net non-operating interest income (expenses)

Non-operating interest income

--1.28M

Non-operating interest expense

--0.00

Income before tax

---24.61M

Income tax

--0.00

Income after tax

---24.61M

Net income from continuous operations

---24.61M

Net income attributable to controlling interests

---24.61M

Net income attributable to common shareholders

---24.61M

Basic earnings per share

---1.49

Diluted earnings per share

---1.49

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

